NM_001164508.2(NEB):c.23599A>C (p.Lys7867Gln) AND Nemaline myopathy 2
- Germline classification:
- Benign (3 submissions)
- Last evaluated:
- Feb 1, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001082596.12
Allele description [Variation Report for NM_001164508.2(NEB):c.23599A>C (p.Lys7867Gln)]
NM_001164508.2(NEB):c.23599A>C (p.Lys7867Gln)
Condition(s)
Assertion and evidence details
Last Updated: Mar 10, 2024